Analgesic effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS) in patients with chronic pain

European Neuropsychopharmacology

Volumn 6, Issue 1, 1996, Pages 43-47

  Takagi, Hiroshi ^a   Harima, Akihiro ^b  

^a Institute of Chronic Pain Research   (Japan)

^b Kyoto Nansei Hospital   (Japan)

Author keywords

Analgesic effect; L threo 3,4 dihydroxyphenylserine; Noradrenaline; Pain

Indexed keywords

3,4 DIHYDROXYPHENYLSERINE; NORADRENALIN; PLACEBO;

ADULT; AGED; ANALGESIA; ANTINOCICEPTION; ARTICLE; CENTRAL NERVOUS SYSTEM; CHRONIC PAIN; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL;

EID: 0029920430     PISSN: 0924977X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0924-977X(95)00058-W     Document Type: Article

References (34)

1. Akaike, A., Shibata, T., Satoh, M. and Takagi, H. (1978) Analgesia induced by microinjection of morphine into and stimulation of the nucleus reticularis paragigantocellularis of rat medulla oblongata. Neuropharmacology, 17, 775-778.
2. Basbaum, A.I. and Fields, H.L. (1984) Endogenous pain control systems: brainstem spinal pathways and endorphin circuitry. Annu. Rev. Neurosci. 7, 309-338.
3. Behbehani, M.M., Pomeroy, S.L. and Mack, C.E. (1981) Interaction between central gray and nucleus raphe magnus: role of norepinephrine. Brain Res. Bull., 6, 361-364.
4. Belcher, G., Ryall, R.W. and Schaffner, R. (1978) The differential effects of 5-hydroxytryptamine, noradrenaline and raphe stimulation on nociceptive and non-nociceptive dorsal horn interneurone in the cat. Brain Res., 151, 307-321.
5. Clark, F.M. and Produfit, H.K. (1991) The projection of noradrenergic neurons in the A7 catecholamine cell group to the spinal cord in the rat demonstrated by anterograde tracing combined with immunocytochemistry. Brain Res., 547, 279-288.
6. Drummond, P.D. (1995) Noradrenaline increases hyperalgesia to heat in skin sensitized by capsaicin. Pain 60, 311-315.
7. Fields, H.L. (1987) Pain. McGraw-Hill, New York, pp. 251-272.
8. Fields, H.L., Heinricher, M.M. and Mason, P. (1991) Neurotransmitters in nociceptive circuits. Annu. Rev. Neurosci. 14, 219-245.
9. Hammond, D.L., Levy, R.A. and Produfit, H.K. (1980) Hypoalgesia following microinjection of noradrenergic antagonists in the nucleus raphe magnus. Pain 9, 85-101.
10. Harima, A., Shimizu, H. and Takagi, H. (1991) Analgesic effect of L-arginine in patients with persistent pain. Eur. Neuropsychopharmacol. 1, 529-533.
11. Headley, P.M., Duggan, A.W. and Gnersmith, B.T. (1978) Selective reduction by noradrenaline and 5-hydroxytryptamine of nociceptive responses of cat dorsal neurons. Brain Res., 145, 185-189.
12. Inagaki, C. and Tanaka, C. (1978) Characteristics of enzymic decarboxylation of L-threo-3,4-dihydroxyphenylserine using hog renal L-aromatic amino acid decarboxylase. Biochem. Pharmacol. 27, 1081-1086.
13. Jänig, W. and Koltzenburg, M. (1992) Possible ways of sympathetic-afferent interactions. In: W. Janig and R.F. Schmidt (Eds.), Reflex Sympathetic Dystrophy: Pathophysiological Mechanisms and Clinical Implications. VCH, New York, pp. 213-243.
14. Karai, N., Kato, T., Katsuyama, M. and Nakamura, M. (1987) Effect of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS. Life Sci. 40, 2261-2268.
15. Kato, T., Karai, N., Katsuyama, M., Nakamura, M. and Katsube, J. (1987) Studies on the activity of L-threo-3,4-dihydroxyphenylserine (L-DOPS) as a catecholamine precursor in the brain. Biochem. Pharmacol. 36, 3051-3057.
16. Kawabata, A., Kasamatsu, K., Umeda, N. and Takagi, H. (1994) The noradrenaline precursor L-threo-3,4-dihydroxy-phenylserine exhibits antinociceptive activity via central α-adrenoceptors in the mouse. Br. J. Pharmacol. 111, 503-508.
17. Kuraishi, Y., Harada, Y. and Takagi, H. (1979) Noradrenaline regulation of pain-transmission in the spinal cord mediated by α-adrenoceptors. Brain Res. 174, 333-336.
18. Kuraishi, Y., Hirota, M., Satoh, M. and Takagi, H. (1985a) Antinociceptive effects of intrathecal opioids, noradrenaline and serotonin in rats: mechanical and thermal algesic tests. Brain Res. 326, 168-171.
19. Kuraishi, Y., Hirota, M., Sato, Y., Kaneko, S., Satoh, M. and Takagi, H. (1985b) Noradrenergic inhibition of release of substance P from the primary afferents in the rabbit spinal dorsal horn. Brain Res. 359, 177-182.
20. Kuraishi, Y., Satoh, M. and Takagi, H. (1987) The descending noradrenergic system and analgesia. In: H. Akil and J.W. Lewis (Eds.), Pain and Headache. Neurotransmitters and Pain Control, Vol. 9, Karger, Basel, pp. 101-128.
21. Narabayashi, H., Kondo, T., Hayashi, A., Suzuki, T. and Nagatsu, T. (1981) L-threo-3,4-dihydroxyphenylserine treatment for akinesia and freezing of parkinsonism. Proc. Jpn. Acad. 57, 351-352.
22. Roberts, W.J. and Elardo, S.M. (1985) Sympathetic activation of A-delta nociceptors. Somatosens. Res. 3, 33-44.
23. Sagen, J. and Produfit, H.K. (1985) Evidence for pain modulation by preand postsynaptic noradrenergic receptors in the medulla oblongata. Brain Res., 331, 285-293.
24. Sato, J. and Perl, E.R. (1991) Adrenergic excitation of cutaneous pain receptors induced by peripheral nerve injury. Science 251, 1608-1610.
25. Satoh, M., Kawajiri, S., Ukai, Y. and Yamamoto, M. (1979) Selective and non-selective inhibition by enkcphalins and noradrenaline of nociceptive responses of lamina V type neurons in the spinal dorsal horn of the rabbit. Brain Res., 177, 384-387.
26. Semba, J. and Takahashi, R. (1985) The effect of L-threo-3,4-dihydroxyphenylseine on norepinephrine metabolism in rat brain. Psychiat. Res. 15, 319-326.
27. Suzuki, T., Higa, S., Tsuge, I., Sakoda, S., Hayashi, A., Yamamura, Y., Tanabe, Y. and Nakajima, A. (1981) Effect of infused L-threo-3,4-dihydroxyphenylserine on adrenergic activity in patients with familial amyloid polyneuropathy. Eur. J. Clin. Pharmacol. 17, 429-435.
28. Takagi, H. (1980) The nucleus reticularis para- gigantocellularis as a site of analgesic action of morphine and enkephalin. Trends Pharmacol. Sci. 1, 182-184.
29. Takagi, H. (1982) Critical review of pain relieving procedures including acupuncture. In: H. Yoshida, Y. Hagiwara and S. Ebashi (Eds.), Advances in Pharmacology and Therapeutics II, Vol. 1. Pergamon, New York, pp. 79-92.
30. Takagi, H. and Harima, A. (1994) A novel clinical treatment of chronic pain with L-threo-3,4-dihydroxyphenylserine (L-DOPS). Can. J. Physiol. Pharmacol. 72, Suppl. 1, 344.
31. Takagi, H., Harima, A. and Shimizu, H. (1990) A novel clinical treatment of persistent pain with L-arginine, Eur. J. Pharmacol. 183, 1443.
32. Wigder, S. and Wilcox, G.L. (1987) Central and systemic morphine-induced antinociception in mice: contribution of descending serotonergic and noradrenergic pathways. J. Pharmacol. Exp. Ther., 242, 90-95.
33. Yaksh, R.P. and Reddy, S.V. (1981) Studies in the primate on the analgesic effects associated with intrathecal actions of opiates, α-adrenergic agonists and baclofen. Anesthesiology 54, 451-467.
34. Yeomans, D.C., Clark, F.M., Paice, J.A. and Produfit, H.K. (1992) Antinociception induced by electrical stimulation of spinally projecting noradrenergic neurons in the A7 catecholamine cell group of the rat. Pain, 48, 449-461.